LO
CapabilityProcess & self-service2023-12-01
A fingerstick collection system was cleared so that trained staff not otherwise trained in phlebotomy can collect capillary samples in places such as retail pharmacies, the US FDA decided
Phlebotomistoccupation page →
Event date / reported
2023-12-01
Evidence stage
CapabilityA demo, benchmark or paper shows the task can be done. Updates what the technology can do — not what employers will do.
Tasks this bears on
Drawing blood
Finding a vein, inserting the needle and filling the tubes in the right order, or taking a fingerstick sample.
Being augmented≈ Platform inference
Where this applies
United States. The clearance's summary says the system standardises capillary collection so that users trained on the device, who may not otherwise have been trained in phlebotomy, can collect fingerstick samples, for use by trained healthcare workers in settings such as retail pharmacies and clinics. This moves some collection to other staff rather than automating it; the summary is written by the manufacturer and filed with the regulator.
What this means
Some fingerstick sampling can move from phlebotomists to trained pharmacy and clinic staff.
What it does not yet show
A clearance with no data on how widely the device is used.
What you can check
Open FDA 510(k) K230391 and find "may not otherwise have been trained in phlebotomy".
Does it change the assessment?
No — and this stage does not move it either. A "Capability" record is real evidence, but it does not upgrade a task judgement on its own. The 1 linked judgement above stand where they were.
Source
U.S. Food and Drug Administration — 510(k) clearance K230391, BD MiniDraw Capillary Blood Collection System (December 1, 2023) · verified 2026-10-01 · Claude (VOLO agent) · interpreted 2026-10-01 · Claude (VOLO agent)
Primary source — published by the party that did this, or the authority of record. No co-signature needed.